Bio-Techne Corporation
TECH
#1800
Rank
$11.351 B
Marketcap
United States
Country
$72.38
Share price
0.32%
Change (1 day)
36.09%
Change (1 year)
Categories
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science…
Key Metrics
Trailing P/E
62.42
Forward P/E
31.40
EPS (TTM)
$1.16
Forward EPS
$2.31
Price / Book
5.36
EV / EBITDA
34.1x
Beta
1.27
Dividend Yield
0.44%
Return on Equity
9.03%
Return on Assets
6.67%
Debt / Equity
13.71
Current Ratio
4.55
Gross Margin
66.24%
Operating Margin
27.87%
Net Profit Margin
14.97%
Free Cash Flow
$229.653M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 17
-0.10%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$1.220B
Latest Net Income$73.400M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Bio-Techne Corporation with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
TECH
No recent news available. Set FINNHUB_API_KEY to enable news.
